Cellular reprogramming is the hottest topic in longevity science, with tech titans like Sam Altman investing in it. It's now ...

Promising mouse studies and billions of dollars in funding are stoking excitement. But we’ve been here before.

During the reprogramming of somatic cells back into stem cells, gene regulation is controlled by pioneer transcription factors. These bind to the tightly packaged DNA in order to make it accessible.

A new study developed a mineralized DNA hydrogel that combines immune regulation with sustained bone regeneration. Using ...

The South San Francisco biotech plans to begin its first human trial of a liver cell-reprogramming therapy next year ...

The outspoken longevity scientist David Sinclair has been predicting that one day, you’ll go to the doctor and get a ...

NewLimit Series C raises $435M led by Founders Fund as Armstrong-backed startup moves epigenetic therapies toward human ...

In a recent study posted to the bioRxiv* preprint server, researchers performed age-reversing experiments, in vivo and in vitro, in progeroid mice using gene therapy. Study: Gene Therapy Mediated ...

Researchers have attained the holy grail of cellular reprogramming: inducing pluripotency without using any DNA-based materials. Using only a cocktail of purified proteins and a chemical additive, ...

The world's first reverse aging drug, ER-100, was injected into a human on June 9, 2026 The post The World’s First ...